Mary Roberts, MPH
Senior Vice President, Market Access Strategy
Market Access
With IRA negotiations, PBM reform, prescription drug affordability boards, and the evolving healthcare landscape, there’s never been a more pivotal time to be at the intersection of health policy and market access strategy. We are uniquely positioned to help our clients navigate these complexities and seize opportunities in these uncertain times.
Solution Spotlight
Our team of former clinicians, operators, payers, and policymakers, collaborate to develop and deliver compelling, data-informed and evidence-driven value stories, accompanying clinical dossiers and tech assessments, pricing tools and launch frameworks.
We proactively and rapidly shape value messaging and evidence in the language and currency of cross payers to achieve swifter time-to-market adoption and reimbursement, achieving success in a rapidly changing political environment.
- Helps you implement innovative payment models every step of the way.
- Delivers guidance, policy translation, and data-driven analysis so you can proactively manage the health of a whole population
- Positions you for successful financial performance as you transition from volume to value.
We’re known for our expertise in:
Bespoke
Solutions
- ADVI SAVEs data-informed real-world evidence and clinical utility strategy
- Pre-launch burden of illness and health technology assessment modeling
- Reimbursement and coding pathways and coverage landscape
- Payer and policymaker deep dive and engagement plans
- Global launch prioritization and market access roadmap
- Product market access and pricing potential assessments
Our Experts
Complementary
Products
ADVI Payerscape™
A sophisticated, curated, data-enabled tool that blends brand or above brand access expectations in the current and evolving market access environment, with ADVI strategic advice, utilizing both ADVI Strategic Analytics and Value Economics (SAVEs) data analysis and payer and policymaker real-time interviews.
Pricing Architecture and Strategy
We determine clinical utility and pricing sensitivity, assess the policy environment, and develop the pricing ethos and product or service value story based on the competitive product landscape, current political norms, appropriate analogs, and horizon scanning.
Value and Outcomes-Based Contract Development or Review
ADVI’s experts develop innovative outcome-based contracting solutions across payers for cell and gene therapy products as well as products in oncology, or population-based contracts for products across commercial payers and in Medicaid.
Need answers
on Market Access?
Connect with our team leader:
Mary Roberts, MPH
Senior Vice President, Market Access Strategy